2 completed, 1 terminated, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
Follow Chronic Obstructive Lung Disease: new trials by email Literature Review of Chronic Obstructive Lung Disease trials Research Report on Chronic Obstructive Lung Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Symbicort ® on GR in Sputum in COPD Symbicort® total dose 400ug/12ug, Symbicort® total dose 800ug/24ug, Formoterol 24ug - Chronic Obstructive Lung Disease | Phase 4 | Completed | Imperial College London | 31 | 2013-01-01 | 2020-11-23 |
| The Pulmonary Protection Trial Perfusion of the lungs, HTK Custodiol, Standard ECC - Chronic Obstructive Lung Disease | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 90 | 2012-07-01 | 2014-04-25 |
| Effects of Symbicort on the Ventilatory Kinematics Budesonide, Symbicort - Chronic Obstructive Lung Disease | Phase 4 | Terminated | Columbia University | 9 | 2012-03-01 | 2016-09-02 |
| Vitamin D and Chronic Obstructive Lung Disease Vitamin D (D3, cholecalciferol), Placebo (cellulose) - Chronic Obstructive Lung Disease | Phase 4 | Withdrawn | Jorgen Vestbo | 2011-09-01 | 2013-04-09 |
Pulmonary Disease, Chronic Obstructive (4)
Chronic Disease (4) · Disease Attributes (4) · Lung Diseases (4) · Lung Diseases, Obstructive (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Respiratory Tract Diseases (4)
Bretschneider cardioplegic solution (1) · Budesonide (1) · Budesonide, Formoterol Fumarate Drug Combination (1) · Cellulose (1) · Cholecalciferol (1) · Formoterol Fumarate (1) · Vitamin D (1)
Columbia University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Imperial College London (1) · Jorgen Vestbo (1)
Denmark (2) · United Kingdom (1) · United States (1)
Matthew Bartels, MD, MPH (1) · Omar S Usmani, PhD (1)